Shares of Immune Therapeutics, Inc. (OTCMKTS:IMUN – Get Free Report) fell 3.2% during mid-day trading on Monday . The company traded as low as $0.26 and last traded at $0.29. 363 shares changed hands during mid-day trading, a decline of 98% from the average session volume of 15,492 shares. The stock had previously closed at […]
Biostax Corp Announces the FDAs Acceptance of Three Investigational New Drug Applications (IND) Transfers for JKB-122 for the Treatment of NASH, NAFLD and AIH itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The "Global Allergy Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027" report has been added to.
– VOWSTTM is the first orally administered microbiome therapeutic FDA-approved for prevention of recurrence of C. difficile infection in adults following antibacterial treatment for recurrent CDI .
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Immune Therapeutics (OTCMKTS:IMUN – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations. Profitability This table compares Regeneron Pharmaceuticals and Immune […]